Accueil › Carcinome épidermoïde de la tête et du cou › Connecticut › New Haven
Essais cliniques pour Carcinome épidermoïde de la tête et du cou à New Haven, CT
22 études pour Carcinome épidermoïde de la tête et du cou recherchent des participants dans et autour de New Haven (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Recrutement en coursPhase 1
- Exelixis Clinical Site #62, New Haven
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Recrutement en coursPhase 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Recrutement en coursPhase 1
- Yale University - Yale University School of Medicine, New Haven
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Recrutement en coursPhase 3
- Yale Cancer Center, New Haven
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Recrutement en coursPhase 1/2
- Yale Cancer Center, New Haven
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recrutement en coursPhase 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Recrutement en coursPhase 1
- Yale University, Yale Cancer Center, New Haven
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Recrutement en coursPhase 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · à 7 mi
- et 1 autres
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Yale Cancer Center, New Haven
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Recrutement en coursPhase 1
- Yale University Cancer Center, New Haven
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Recrutement en coursPhase 1
- Normunity Investigational Site, New Haven
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Recrutement en coursPhase 2/3
- Yale University, New Haven
CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
Recrutement en coursPhase 2Volontaires sains bienvenus
- Yale University, New Haven
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Recrutement en coursPhase 1/2
- Yale Comprehensive Cancer Center, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Yale University, Yale Cancer Center, New Haven
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
Recrutement en coursPhase 2
- Yale University, New Haven
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Recrutement en coursPhase 1
- Yale University School of Medicine /ID# 225707, New Haven
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Recrutement en coursPhase 3
- GSK Investigational Site, New Haven
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Recrutement en coursPhase 3
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Recrutement en coursPhase 1/2
- Yale Cancer Center, New Haven
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Recrutement en coursPhase 1/2
- Yale Cancer Center, New Haven
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
Recrutement en coursPhase 2
- Yale, New Haven
Essais pour Carcinome épidermoïde de la tête et du cou dans d'autres villes
- Houston, TX47 études
- Los Angeles, CA42 études
- Boston, MA40 études
- New York City, NY39 études
- Nashville, TN39 études
- St. Louis, MO28 études
- Arlington, VA26 études
- Philadelphia, PA26 études
- Chicago, IL26 études
- Atlanta, GA24 études
- San Antonio, TX22 études
- Pittsburgh, PA22 études
Autres études à New Haven
- Cancer du poumon non à petites cellules41 études
- Cancer du sein38 études
- Cancer (tous types)33 études
- Cancer métastatique23 études
- Cancer du poumon22 études
- Cancer de l'ovaire21 études
- Cancer colorectal20 études
- Cancer de la prostate20 études
- Leucémie aiguë myéloïde17 études
- Trouble de l'usage de l'alcool (TUA)17 études
- Surdose d'opioïdes17 études
- Cancer du pancréas16 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.